The effectiveness of N-acetylcysteine in preventing contrast-induced nephropathy in patients undergoing contrast-enhanced computed tomography: A meta-analysis of randomized controlled trials

International Urology and Nephrology

Volumn 45, Issue 5, 2013, Pages 1309-1318

  Wu, Mei Yi ^a   Hsiang, Hui Fen ^b   Wong, Chung Shun ^c   Yao, Min Szu ^d   Li, Yun Wen ^b   Hsiang, Chao Ying ^b   Bai, Chyi Huey ^e   Hsu, Yung Ho ^a   Lin, Yuh Feng ^a   Tam, Ka Wai ^b,e  

^a Shuang Ho Hospital   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^c TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^d TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^e TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Computed tomography; Contrast induced nephropathy; Meta analysis; N Acetylcysteine

Indexed keywords

ACETYLCYSTEINE; ALPHA TOCOPHEROL; CREATININE; CYSTATIN C; IOHEXOL; IOPROMIDE;

ACUTE KIDNEY FAILURE; ARTICLE; CHRONIC KIDNEY FAILURE; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; CONTRAST INDUCED NEPHROPATHY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DRUG EFFICACY; HUMAN; HYDRATION; INCIDENCE; INTENTION TO TREAT ANALYSIS; META ANALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTCOME ASSESSMENT; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; SYSTEMATIC REVIEW;

ACETYLCYSTEINE; ACUTE KIDNEY INJURY; CONTRAST MEDIA; CREATININE; CYSTATIN C; FLUID THERAPY; FREE RADICAL SCAVENGERS; GLOMERULAR FILTRATION RATE; HUMANS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RENAL DIALYSIS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84881478827     PISSN: 03011623     EISSN: 15732584     Source Type: Journal    
DOI: 10.1007/s11255-012-0363-1     Document Type: Article

References (23)

1. Parfrey PS, Griffiths SM, Barrett BJ et al (1989) Contrast material-induced renal failure in patients with diabetes mellitus, renal insufficiency, or both. A prospective controlled study. N Engl J Med 320:143-149
2. Weisbord SD, Mor MK, Resnick AL et al (2008) Prevention, incidence, and outcomes of contrast-induced acute kidney injury. Arch Intern Med 168:1325-1332
3. Mitchell AM, Jones AE, Tumlin JA, Kline JA (2010) Incidence of contrast-induced nephropathy after contrast-enhanced computed tomography in the outpatient setting. Clin J Am Soc Nephrol 5:4-9
4. Thomsen HS, Morcos SK (2006) Contrast-medium-induced nephropathy: is there a new consensus? A review of published guidelines. Eur Radiol 16:1835-1840
5. Sandstede JJ, Roth A, Machann W, Kaupert C, Hahn D (2007) Evaluation of the nephrotoxicity of iodixanol in patients with predisposing factors to contrast medium induced nephropathy referred for contrast enhanced computed tomography. Eur J Radiol 63:120-123
6. Huber W, Eckel F, Hennig M et al (2006) Prophylaxis of contrast material-induced nephropathy in patients in intensive care: acetylcysteine, theophylline, or both? A randomized study. Radiology 239:793-804
7. Baliga R, Ueda N, Walker PD, Shah SV (1997) Oxidant mechanisms in toxic acute renal failure. Am J Kidney Dis 29:465-477
8. Kelly AM, Dwamena B, Cronin P, Bernstein SJ, Carlos RC (2008) Meta-analysis:effectiveness of drugs for preventing contrast-induced nephropathy. Ann Intern Med 148:284-294
9. Liberati A, Altman DG, Tetzlaff J et al (2009) The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. J Clin Epidemiol 62:e1-e34
10. DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7:177-188
11. Burns KE, Priestap F, Martin C (2010) N-acetylcysteine in critically ill patients undergoing contrast-enhanced computed tomography: a randomized trial. Clin Nephrol 74:323-326
12. Poletti PA, Saudan P, Platon A et al (2007) I.v. N-acetylcysteine and emergency CT: use of serum creatinine and cystatin C as markers of radiocontrast nephrotoxicity. AJR Am J Roentgenol 189:687-692
13. Sar F, Saler T, Ecebay A, Saglam ZA, Ozturk S, Kazancioglu R (2010) The efficacy of n-acetylcysteine in preventing contrast-induced nephropathy in type 2 diabetic patients without nephropathy. J Nephrol 23:478-482
14. Tepel M, van der Giet M, Schwarzfeld C, Laufer U, Liermann D, Zidek W (2000) Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine. N Engl J Med 343:180-184
15. Hsu TF, Huang MK, Yu SH et al (2012) N-acetylcysteine for the prevention of contrast-induced nephropathy in the emergency department. Intern Med 51:2709-2714
16. Kitzler TM, Jaberi A, Sendlhofer G et al (2012) Efficacy of vitamin E and N-acetylcysteine in the prevention of contrast induced kidney injury in patients with chronic kidney disease: a double blind, randomized controlled trial. Wien Klin Wochenschr 124:312-319
17. Perkins BA, Nelson RG, Ostrander BE et al (2005) Detection of renal function decline in patients with diabetes and normal or elevated GFR by serial measurements of serum cystatin C concentration: results of a 4-year follow-up study. J Am Soc Nephrol 16:1404-1412
18. Trivedi H, Daram S, Szabo A, Bartorelli AL, Marenzi G (2009) High-dose N-acetylcysteine for the prevention of contrast-induced nephropathy. Am J Med 122(874):e9-e15
19. Mueller C, Buerkle G, Buettner HJ et al (2002) Prevention of contrast media-associated nephropathy: randomized comparison of 2 hydration regimens in 1620 patients undergoing coronary angioplasty. Arch Intern Med 162:329-336
20. Thiele H, Hildebrand L, Schirdewahn C et al (2010) Impact of high-dose N-acetylcysteine versus placebo on contrast-induced nephropathy and myocardial reperfusion injury in unselected patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. The LIPSIA-N-ACC (Prospective, Single-Blind, Placebo-Controlled, Randomized Leipzig Immediate Percutaneous Coronary Intervention Acute Myocardial Infarction N-ACC) trial. J Am Coll Cardiol 55:2201-2209
21. Brown JR, Block CA, Malenka DJ, O'Connor GT, Schoolwerth AC, Thompson CA (2009) Sodium bicarbonate plus N-acetylcysteine prophylaxis: a meta-analysis. JACC Cardiovasc Interv 2:1116-1124
22. Herts BR, Schneider E, Poggio ED, Obuchowski NA, Baker ME (2008) Identifying outpatients with renal insufficiency before contrast-enhanced CT by using estimated glomerular filtration rates versus serum creatinine levels. Radiology 248:106-113
23. Rehman T, Fought J, Solomon R (2008) N-acetylcysteine effect on serum creatinine and cystatin C levels in CKD patients. Clin J Am Soc Nephrol 3:1610-1614